Aytu BioPharma: Q3 Earnings Insights

Aytu BioPharma AYTU reported its Q3 earnings results on Thursday, May 11, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Aytu BioPharma missed estimated earnings by 206.35%, reporting an EPS of $-1.93 versus an estimate of $-0.63.

Revenue was down $1.47 million from the same period last year.

Last quarter the company missed on EPS by $0.55 which was followed by a 5.78% drop in the share price the next day.

Here's a look at Aytu BioPharma's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	-1.60	-3.6	-7.4	-8.2
EPS Actual	-2.15	-1.2	-9.8	-5.4
Revenue Estimate	26.40M	24.30M	25.50M	24.80M
Revenue Actual	26.28M	27.66M	27.45M	24.20M

To track all earnings releases for Aytu BioPharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar